LFLaila Aly Farid

Laila Aly Farid

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Laila Aly Farid has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Effect of Sildenafil Citrate on the Neonatal Outcome of Growth Restricted Foetuses

    by Laila Farid, Khaled Mousa, Marwa Yousef

    Background: Poor growth of a foetus during pregnancy is referred to as intrauterine growth restriction (IUGR), also known as intrauterine growth retardation. There are several potential reasons, but inadequate maternal nutrition or insufficient oxygen delivery to the foetus are the most frequent ones.The purpose of the work is to determine how sildenafil citrate affects newborn outcomes such as birth weight and admission to the neonatal intensive care unit (NICU).Patients and Methods: A total of 120 pregnant women between the ages of 28 and 30 who were attending antenatal care clinics or being admitted to the obstetrics and gynaecology department and had FGR,defined as a lag of two weeks or more between the current biometric measurements and the documented pregnancy dating to the first trimester and anestimated foetal weight less than the 10th percentile for gestational age, were included in this randomised controlled trial study.Results: In comparison to 40.0% and 73.3% in the control group, 21.7% of neonates in the sildenafil group have an APGAR5 score 7 and 48.3% of them are admitted to the NICU, a significant difference between the two groups(p=0.030 &0.005, respectively). In the sildenafil group, sildenafil reduced the relative risk of both by 0.62&0.60.Conclusion: One of the biggest problems in maternity care today, as well as one of the leading causes of perinatal morbidity and death, is intrauterine growth restriction (IUGR). notwithstanding the significant strain it places on maternity and paediatric healthcare. We are still looking for a cure that will last forever. In the current study, it was discovered that sildenafil increases gestational age, prolongs pregnancy,improves birth weight, lowers the incidence of CS, and lessens IUGR-related problems.

  • Open Access

    Uterine CD56dim and CD16+ Cells in Refractory Antiphospholipid Antibody-Related Pregnancy Loss and Chromosomally Intact Abortuses: A Case–Control Study

    by Mostafa F. Gomaa, Abdeiiatif G. Elkhouly, Mohammad M. Farghly, Laila A. Farid, Nahla M. Awad

    To evaluate the role of uterine natural killer (uNK) CD56dim and CD16+ cells in patients with refractory antiphospholipid, antibody-mediated, recurrent, pregnancy loss. A case–control study was conducted between 2012 and 2015 at a university hospital. A group of 118 women with a history of antiphospholipid antibody syndrome experiencing fetal loss in spite of low dose aspirin (LDA) and low molecular weight heparin (LMWH) treatment in the current pregnancy were included in this study. A group of 32 patients undergoing an elective termination of viable pregnancies before 20 weeks were taken as controls. Suction evacuation was performed to collect abortus specimens, and uterine wall curettage was performed to collect decidua specimens, which were then stained using monoclonal antibodies specific to CD56 and CD16. Statistical analyses were performed using the Statistical Package for the Social Sciences version 18 software. Chi-square and Fisher exact tests were used for making comparison between the groups. Abnormal fetal karyotype was found in nine (9/97) cases of the study group, which means that abnormal karyotype accounts for only 9.3% of the causes of failure of treatment. Abnormal karyotype was found in four cases of the control group. Only cases with normal karyotyping were subjected to decidual uNK cells analysis. We found that CD56dim and CD16+ were found in the decidua of 79 cases (79/97), which means that aberrant natural killer cells expression might account for 81.4% of the cases of refractory antiphospholipid antibody (APA)-mediated recurrent pregnancy loss. CD56dim and CD16+ uNK cells might be correlated with refractory APA-mediated recurrent pregnancy loss.


  • Uterine natural killer cells dysregulation in idiopathic human preterm birth: a pilot study

    by Mostafa Fouad Gomaa, Ihab Fouad Serag Eldeen, Laila Aly Farid, Mourad Mohey Eldeen El-Saeed, Ahmed Mohammed Abas, Nahla Mohammad Aawd

    Objective: To compare between uterine natural killer (uNK) cells in the placental samples of preterm birth and term labor. Study design: Two-arm case–control study. This study included 60 participants divided into two groups. The first group included 30 cases of idiopathic spontaneous preterm labor and the other group included 30 women who delivered by a spontaneous term vaginal delivery and with no history of previous preterm labor. Result(s): There were no CD16− CD56bright uNK cells in either groups; CD16+ CD56dim uNK cells were present in only 1 case out of 30 term delivery placentae (3.3%), whereas they were found in 21 cases out of 30 (70%) preterm placental samples with a significant statistical difference (p < 0.0001) and OR 67.667, 95% CI (7.95–575.69). CD16+CD56dim uNK cells were found to be invading both the villi and the decidua in 11 cases (70%), whereas those cells were found invading only the villi in 10 cases (33.3%). Conclusion: CD16+CD56dim cells are expressed in both the decidua and the villi of patients with idiopathic preterm labor suggesting an association between uNK cells dysregulation and idiopathic human preterm labor.